Downregulation of telomerase activity by diclofenac and curcumin is associated with cell cycle arrest and induction of apoptosis in colon cancer
- 6 March 2015
- journal article
- Published by Springer Nature in Tumor Biology
- Vol. 36 (8) , 5999-6010
Abstract
Uncontrolled cell proliferation is the hallmark of cancer, and cancer cells have typically acquired damage to genes that directly regulate their cell cycles. The synthesis of DNA onto the end of chromosome during the replicative phase of cell cycle by telomerase may be necessary for unlimited proliferation of cells. Telomerase, a ribonucleoprotein enzyme is considered as a universal therapeutic target of cancer because of its preferential expression in cancer cells and its presence in 90 % of tumors. We studied the regulation of telomerase and telomerase reverse transcriptase catalytic subunit (TERT) by diclofenac and curcumin, alone and also in combination, in 1, 2-dimethylhydrazine dihydrochloride-induced colorectal cancer in rats. The relationship of telomerase activity with tumors suppressor proteins (p51, Rb, p21), cell cycle machinery, and apoptosis was also studied. Telomerase is highly expressed in DMH group and its high activity is associated with increased TERT expression. However, telomerase is absent or is present at lower levels in normal tissue. CDK4, CDK2, cyclin D1, and cyclin E are highly expressed in DMH as assessed by RT-PCR, qRT-PCR, Western blot, and immunofluorescence analysis. Diclofenac and curcumin overcome these carcinogenic effects by downregulating telomerase activity, diminishing the expression of TERT, CDK4, CDK2, cyclin D1, and cyclin E. The anticarcinogenic effects shown after the inhibition of telomerase activity by diclofenac and curcumin may be associated with upregulation of tumor suppressor proteins p51, Rb, and p21, whose activation induces the cells cycle arrest and apoptosis.Keywords
This publication has 41 references indexed in Scilit:
- Inhibition of cell proliferation and induction of apoptosis by oleanane triterpenoid (CDDO-Me) in pancreatic cancer cells is associated with the suppression of hTERT gene expression and its telomerase activityBiochemical and Biophysical Research Communications, 2012
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Cell cycle, CDKs and cancer: a changing paradigmNature Reviews Cancer, 2009
- Docking of molecules identified in bioactive medicinal plants extracts into the p50 NF-kappaB transcription factor: correlation with inhibition of NF-kappaB/DNA interactions and inhibitory effects on IL-8 gene expressionBMC Structural Biology, 2008
- Increased copy number of the TERT and TERC telomerase subunit genes in cancer cellsCancer Science, 2008
- Telomerase reverse transcriptase regulates the expression of a key cell cycle regulator, cyclin D1Biochemical and Biophysical Research Communications, 2006
- A Human Telomerase-associated NucleaseMolecular Biology of the Cell, 2004
- Inhibition of telomerase activity in endometrial cancer cells by selenium‐cisplatin conjugate despite suppression of its DNA‐damaging activity by sodium ascorbateTeratogenesis, Carcinogenesis, and Mutagenesis, 2001
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976